• Mashup Score: 7

    Abstract. Pharmacological inhibition of epigenetic enzymes can have therapeutic benefit against hematological malignancies. In addition to affecting tumor cell growth and proliferation, these epigenetic agents may induce anti-tumor immunity. Here we discovered a novel immuno-regulatory mechanism through inhibition of histone deacetylases (HDACs). In models of AML, leukemia cell differentiation…

    Tweet Tweets with this article
    • Epigenetic activation of plasmacytoid #dendriticcells drives IFNAR-dependent therapeutic #differentiation of acute myeloid #leukemia by @salmon_jess et al. https://t.co/0smmpxSKzD @todorovizabela @Pilar_dominguez @JohnstoneRicky @JohnstoneLab @PeterMacCC @PeterMacRes #leusm https://t.co/awr0q03f0Z